Cancer BiologybioRxiv
Fasting reverses drug-resistance in hepatocellular carcinoma through p53-dependent metabolic synergism
J. Krstic, I. Reinisch, K. Schindlmaier…·A. Prokesch
This study shows that fasting enhances the effectiveness of sorafenib in hepatocellular carcinoma by reversing drug resistance through p53-dependent metabolic changes.
DOI 10.1126/sciadv.abh2635